EMT inhibitor-1 is primarily used in biomedical research to study the process of epithelial-mesenchymal transition (EMT), a critical mechanism in cancer metastasis and fibrosis. By inhibiting EMT, this compound helps researchers understand how cancer cells acquire invasive properties and spread to distant organs. It is also employed in drug development to identify potential therapeutic agents that can block EMT, thereby preventing tumor progression and improving treatment outcomes. Additionally, EMT inhibitor-1 is utilized in studies focused on tissue regeneration and wound healing, as EMT plays a role in these processes. Its application extends to exploring its effects on fibrotic diseases, where EMT contributes to the excessive accumulation of extracellular matrix components. Furthermore, it is studied for its efficacy in reducing cancer cell resistance to chemotherapy, potentially leading to more effective cancer therapies.